Transtympanic corticoid therapy for acute profound hearing loss.
about
Intratympanic glucocorticoids for sudden sensorineural hearing lossHearing Changes After Intratympanically Applied Steroids for Primary Therapy of Sudden Hearing Loss: A Meta-analysis Using Mathematical Simulations of Drug Delivery Protocols.Therapy of hearing disorders - conservative procedures.Drug delivery for treatment of inner ear disease: current state of knowledgeAre intra-tympanically administered steroids effective in patients with sudden deafness? Implications for current clinical practice.Intratympanic steroids for sudden sensorineural hearing loss: a systematic review.Intratympanic steroids as a salvage treatment for sudden sensorineural hearing loss? A meta-analysis.Potential Benefits of Combination Therapy as Primary Treatment for Sudden Sensorineural Hearing Loss.Dexamethasone concentration gradients along scala tympani after application to the round window membrane.Cochlear microdialysis for quantification of dexamethasone and fluorescein entry into scala tympani during round window administration.Effectiveness of intratympanic dexamethasone for refractory sudden sensorineural hearing loss.Efficacy of 3 different steroid treatments for sudden sensorineural hearing loss: a prospective, randomized trial.Steroid-based treatments for patients with total sudden sensorineural hearing loss.Corticosteroid treatment of idiopathic sudden sensorineural hearing loss: analysis of an RCT and material drawn from the Swedish national database.Efficacy of intratympanic steroid therapy for idiopathic sudden sensorineural hearing loss: comparison with systemic steroid therapy and combined therapy.Early combination treatment with intratympanic steroid injection in severe to profound sudden sensorineural hearing loss improves speech discrimination performance.Intratympanic steroids for treatment of sudden hearing loss after failure of intravenous therapy.
P2860
Q24240942-01FE8D76-33F2-4FB9-AEAE-DF5D184C25C0Q30313800-7BF525B4-EF6F-47F3-97ED-8919B4689F7CQ30473039-467C070A-006D-441C-9A54-6314C8FD0244Q30476020-48325ADC-64FC-4295-98AC-F103C5421A7BQ37919754-B0701E1E-DB0C-4717-97CA-4CA95AC81523Q37923244-17C93B93-251E-4976-8B29-10A6B7C1A25CQ38248769-956C0143-6CE5-4446-90E9-A17142049704Q38630063-05DC3AB8-D31C-4259-896C-2B3F34A7E3E9Q41641420-F80B3854-A1D7-4B8B-887A-C979ADE496D6Q41890379-F40791D6-5075-42E2-94EF-7E635F9DFB56Q45104745-D5952806-DB48-4B9E-AB6D-F3802D1C7827Q46160725-9AC05A35-8B32-48BC-AAEF-D1D72ABFE507Q50352733-A3CA4E0D-FAF5-4FC5-AEA9-B6162892B1BEQ50353981-6F25CC7C-3400-460A-B005-FA2F28A3B27BQ50357700-781F75AB-E9B9-4DC9-9475-A673E1521461Q50432245-D87956FA-27D3-47ED-B066-2CC42C0CF39EQ50456895-27A53DB0-DB60-4811-8F82-B02697262BF4
P2860
Transtympanic corticoid therapy for acute profound hearing loss.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Transtympanic corticoid therapy for acute profound hearing loss.
@en
Transtympanic corticoid therapy for acute profound hearing loss.
@nl
type
label
Transtympanic corticoid therapy for acute profound hearing loss.
@en
Transtympanic corticoid therapy for acute profound hearing loss.
@nl
prefLabel
Transtympanic corticoid therapy for acute profound hearing loss.
@en
Transtympanic corticoid therapy for acute profound hearing loss.
@nl
P2093
P1476
Transtympanic corticoid therapy for acute profound hearing loss.
@en
P2093
Holger Sudhoff
Jürgen Lautermann
Rüdiger Junker
P2888
P304
P356
10.1007/S00405-004-0876-Z
P577
2005-03-03T00:00:00Z
P6179
1015758341